187 related articles for article (PubMed ID: 16675709)
1. Tetracycline-controlled transgenic targeting from the SCL locus directs conditional expression to erythrocytes, megakaryocytes, granulocytes, and c-kit-expressing lineage-negative hematopoietic cells.
Bockamp E; Antunes C; Maringer M; Heck R; Presser K; Beilke S; Ohngemach S; Alt R; Cross M; Sprengel R; Hartwig U; Kaina B; Schmitt S; Eshkind L
Blood; 2006 Sep; 108(5):1533-41. PubMed ID: 16675709
[TBL] [Abstract][Full Text] [Related]
2. The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1.
Lécuyer E; Herblot S; Saint-Denis M; Martin R; Begley CG; Porcher C; Orkin SH; Hoang T
Blood; 2002 Oct; 100(7):2430-40. PubMed ID: 12239153
[TBL] [Abstract][Full Text] [Related]
3. The critical regulator of embryonic hematopoiesis, SCL, is vital in the adult for megakaryopoiesis, erythropoiesis, and lineage choice in CFU-S12.
Hall MA; Curtis DJ; Metcalf D; Elefanty AG; Sourris K; Robb L; Gothert JR; Jane SM; Begley CG
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):992-7. PubMed ID: 12552125
[TBL] [Abstract][Full Text] [Related]
4. Different sequence requirements for expression in erythroid and megakaryocytic cells within a regulatory element upstream of the GATA-1 gene.
Vyas P; McDevitt MA; Cantor AB; Katz SG; Fujiwara Y; Orkin SH
Development; 1999 Jun; 126(12):2799-811. PubMed ID: 10331989
[TBL] [Abstract][Full Text] [Related]
5. Expression of tal-1 and GATA-binding proteins during human hematopoiesis.
Mouthon MA; Bernard O; Mitjavila MT; Romeo PH; Vainchenker W; Mathieu-Mahul D
Blood; 1993 Feb; 81(3):647-55. PubMed ID: 7678994
[TBL] [Abstract][Full Text] [Related]
6. Enhanced megakaryocyte and erythroid development from normal human CD34(+) cells: consequence of enforced expression of SCL.
Elwood NJ; Zogos H; Pereira DS; Dick JE; Begley CG
Blood; 1998 May; 91(10):3756-65. PubMed ID: 9573012
[TBL] [Abstract][Full Text] [Related]
7. The SCL +40 enhancer targets the midbrain together with primitive and definitive hematopoiesis and is regulated by SCL and GATA proteins.
Ogilvy S; Ferreira R; Piltz SG; Bowen JM; Göttgens B; Green AR
Mol Cell Biol; 2007 Oct; 27(20):7206-19. PubMed ID: 17709394
[TBL] [Abstract][Full Text] [Related]
8. Opposing effects of the basic helix-loop-helix transcription factor SCL on erythroid and monocytic differentiation.
Hoang T; Paradis E; Brady G; Billia F; Nakahara K; Iscove NN; Kirsch IR
Blood; 1996 Jan; 87(1):102-11. PubMed ID: 8547631
[TBL] [Abstract][Full Text] [Related]
9. Deletion of the Scl +19 enhancer increases the blood stem cell compartment without affecting the formation of mature blood lineages.
Spensberger D; Kotsopoulou E; Ferreira R; Broccardo C; Scott LM; Fourouclas N; Ottersbach K; Green AR; Göttgens B
Exp Hematol; 2012 Jul; 40(7):588-598.e1. PubMed ID: 22401818
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of the SCL locus: identification of an enhancer that targets the primitive erythroid lineage in vivo.
Delabesse E; Ogilvy S; Chapman MA; Piltz SG; Gottgens B; Green AR
Mol Cell Biol; 2005 Jun; 25(12):5215-25. PubMed ID: 15923636
[TBL] [Abstract][Full Text] [Related]
11. Aberrant mast-cell differentiation in mice lacking the stem-cell leukemia gene.
Salmon JM; Slater NJ; Hall MA; McCormack MP; Nutt SL; Jane SM; Curtis DJ
Blood; 2007 Nov; 110(10):3573-81. PubMed ID: 17644741
[TBL] [Abstract][Full Text] [Related]
12. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages.
Porcher C; Swat W; Rockwell K; Fujiwara Y; Alt FW; Orkin SH
Cell; 1996 Jul; 86(1):47-57. PubMed ID: 8689686
[TBL] [Abstract][Full Text] [Related]
13. The scl +18/19 stem cell enhancer is not required for hematopoiesis: identification of a 5' bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1.
Göttgens B; Broccardo C; Sanchez MJ; Deveaux S; Murphy G; Göthert JR; Kotsopoulou E; Kinston S; Delaney L; Piltz S; Barton LM; Knezevic K; Erber WN; Begley CG; Frampton J; Green AR
Mol Cell Biol; 2004 Mar; 24(5):1870-83. PubMed ID: 14966269
[TBL] [Abstract][Full Text] [Related]
14. Rescue of the lethal scl(-/-) phenotype by the human SCL locus.
Sinclair AM; Bench AJ; Bloor AJ; Li J; Göttgens B; Stanley ML; Miller J; Piltz S; Hunter S; Nacheva EP; Sanchez MJ; Green AR
Blood; 2002 Jun; 99(11):3931-8. PubMed ID: 12010791
[TBL] [Abstract][Full Text] [Related]
15. The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis.
Kallianpur AR; Jordan JE; Brandt SJ
Blood; 1994 Mar; 83(5):1200-8. PubMed ID: 8118024
[TBL] [Abstract][Full Text] [Related]
16. Transcription of the SCL gene in erythroid and CD34 positive primitive myeloid cells is controlled by a complex network of lineage-restricted chromatin-dependent and chromatin-independent regulatory elements.
Göttgens B; McLaughlin F; Bockamp EO; Fordham JL; Begley CG; Kosmopoulos K; Elefanty AG; Green AR
Oncogene; 1997 Nov; 15(20):2419-28. PubMed ID: 9395238
[TBL] [Abstract][Full Text] [Related]
17. Genetic interaction between Kit and Scl.
Lacombe J; Krosl G; Tremblay M; Gerby B; Martin R; Aplan PD; Lemieux S; Hoang T
Blood; 2013 Aug; 122(7):1150-61. PubMed ID: 23836559
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional link between blood and bone: the stem cell leukemia gene and its +19 stem cell enhancer are active in bone cells.
Pimanda JE; Silberstein L; Dominici M; Dekel B; Bowen M; Oldham S; Kallianpur A; Brandt SJ; Tannahill D; Göttgens B; Green AR
Mol Cell Biol; 2006 Apr; 26(7):2615-25. PubMed ID: 16537906
[TBL] [Abstract][Full Text] [Related]
19. Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis.
Gekas C; Rhodes KE; Gereige LM; Helgadottir H; Ferrari R; Kurdistani SK; Montecino-Rodriguez E; Bassel-Duby R; Olson E; Krivtsov AV; Armstrong S; Orkin SH; Pellegrini M; Mikkola HK
Blood; 2009 Apr; 113(15):3461-71. PubMed ID: 19211936
[TBL] [Abstract][Full Text] [Related]
20. An SCL 3' enhancer targets developing endothelium together with embryonic and adult haematopoietic progenitors.
Sánchez M; Göttgens B; Sinclair AM; Stanley M; Begley CG; Hunter S; Green AR
Development; 1999 Sep; 126(17):3891-904. PubMed ID: 10433917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
